Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL PHARMA Gains 6%; BSE HEALTHCARE Index Up 1.8%
Wed, 7 Aug 14:29

PIRAMAL PHARMA Gains 6%; BSE HEALTHCARE Index Up 1.8%Image source: phive2015/www.istockphoto.com

PIRAMAL PHARMA share price has zoomed 6% and is presently trading at Rs 177.1.

Meanwhile, the BSE HEALTHCARE index is at 40,750.0 (up 1.8%).

Among the top gainers in the BSE HEALTHCARE index today are AJANTA PHARMA (up 5.6%) and ASTER DM HEALTHCARE (up 4.4%).

GLAND PHARMA (down 4.1%) and FORTIS HEALTHCARE (down 2.5%) are among the top losers today.

Over the last one year, PIRAMAL PHARMA has moved up from Rs 101.7 to Rs 177.1, registering a gain of Rs 75.5 (up 74.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 40,750.0, registering a gain of 44.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 114.5%), SUVEN PHARMACEUTICALS (up 104.6%) and GRANULES INDIA (up 104.0%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,346.8 (up 1.0%).

The top gainers among the BSE Sensex today are MUNDRA PORT & SEZ (up 3.1%) and Power Grid Corp. (up 3.0%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 24,273.4 (up 1.2%). ONGC and Coal India are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,346.8, registering a gain of 13,393.3 points (up 20.3%).

PIRAMAL PHARMA Financial Update...

PIRAMAL PHARMA net profit grew 1.7% YoY to Rs -1,110 million for the quarter ended June 2024, compared to a loss of Rs 1,130 million a year ago. Net sales rose 11.6% to Rs 19,511 million during the period as against Rs 17,489 million in April-June 2023.

For the year ended March 2024, PIRAMAL PHARMA reported 109.6% increase in net profit to Rs 178 million compared to net loss of Rs 1,865 million during FY23. Revenue of the company grew 15.4% to Rs 81,712 million during FY24.

The current Price to earnings ratio of PIRAMAL PHARMA, based on rolling 12 month earnings, stands at -590.9.


Equitymaster requests your view! Post a comment on "PIRAMAL PHARMA Gains 6%; BSE HEALTHCARE Index Up 1.8%". Click here!